Stanford is one of four testing sites for a clinical trial of a new smallpox vaccine from biopharmaceutical company VaxGen Inc., though it is unclear whether the University will profit from the trial.
Stanford is one of four testing sites for a clinical trial of a new smallpox vaccine from biopharmaceutical company VaxGen Inc., though it is unclear whether the University will profit from the trial.
